logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Pharmaceutical Anticounterfeiting Combating The Real Danger From Fake Drugs 1st Edition Mark Davison

  • SKU: BELL-2485610
Pharmaceutical Anticounterfeiting Combating The Real Danger From Fake Drugs 1st Edition Mark Davison
$ 31.00 $ 45.00 (-31%)

4.4

12 reviews

Pharmaceutical Anticounterfeiting Combating The Real Danger From Fake Drugs 1st Edition Mark Davison instant download after payment.

Publisher: Wiley
File Extension: PDF
File size: 2.73 MB
Pages: 400
Author: Mark Davison
ISBN: 9780470616178, 9781118023679, 0470616172, 1118023676
Language: English
Year: 2011
Edition: 1

Product desciption

Pharmaceutical Anticounterfeiting Combating The Real Danger From Fake Drugs 1st Edition Mark Davison by Mark Davison 9780470616178, 9781118023679, 0470616172, 1118023676 instant download after payment.

This book overviews and integrates the business and technical issues that pharmaceutical companies need to know in order to combat the major global problem of counterfeit medicines. In addition to discussion of the problems, the author Davison addresses analytical techniques scientists use to detect counterfeits and presents some possible solutions to the threat of counterfeit medical products. Coverage moves from basic overview of the problem, costs / risks to consumers (toxic products, mistrust of drug companies) and business (revenue loss, public trust), government oversight and regulation, authentication strategies (packaging, analytical techniques), product tracking and supply chain, and case studies from around the globe.

Related Products